Sanara MedTech Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio3.355.408.249.3420.15
P/B Ratio7.467.879.067.4853.78
Price/Tangible Book56.268.70102.87
Enterprise Value Ratios
EV/Revenue3.525.488.028.4120.07
Profitability & Returns
Return on Equity (ROE)-0.24%-0.10%-0.23%-0.44%-0.73%
Return on Assets (ROA)-0.04%-0.07%-0.15%-0.20%-0.30%
Return on Capital Employed (ROCE)-0.08%-0.13%-0.25%-0.24%-0.80%
Leverage & Solvency Ratios
Debt/Equity0.830.260.020.010.08
Liquidity Ratios
Current Ratio2.181.381.614.091.27
Quick Ratio1.850.991.253.590.77
Efficiency Ratios
Asset Turnover1.070.960.941.041.49
Inventory Turnover2.181.902.271.451.71
Yield & Distribution Ratios
Earnings Yield-0.03%-0.01%-0.02%-0.04%-0.01%
FCF Yield0.00%-0.01%-0.02%-0.02%-0.01%
Buyback Yield-0.02%-0.05%-0.08%-0.28%-1.69%